PT Astellas Pharma Indonesia

PT Astellas Pharma Indonesia was established in the year 2000 as P.T. Yamanouchi Indonesia, a subsidiary of Yamanouchi Pharmaceutical Co., Ltd., a pharmaceutical company based in Japan

On April 1st, 2005, Astellas Pharma Inc. was established through a merger of Yamanouchi Pharmaceutical Company Limited and Fujisawa Pharmaceutical Company Limited. Following this merger, PT Yamanouchi Indonesia changed its name to PT Astellas Pharma Indonesia.

Being a member of the International Pharmaceutical Manufacturers Group (IPMG) in Indonesia, PT Astellas Pharma Indonesia is committed to delivering pharmaceutical products that are safe, innovative and reliable.

Our products in Indonesia consisted of antifungal (Mycamine), immunosuppresant (Prograf, Prograf XL), oncology (Xtandi), and urology (Harnal, Vesicare, Betmiga).

Astellas is committed to providing a brighter future for our stakeholders, including patients and their families, healthcare personnel, shareholders, employees and the global community. Our communication slogan, "Changing tomorrow," express our pledge to develop new medicines that are vital to patients worldwide. At the same time, this means that Astellas hopes to share in the bravery, hope, and desires of patients.